Blood pressure monitor versus single-lead ECG for finding atrial fibrillation in older adults
Compares a blood pressure monitor with single-lead ECG to detect atrial fibrillation in older adults.
Plain-language title generated from the registry record
Registry title: Electronic Blood Pressure Monitor for Atrial Fibrillation Detection
Key facts
- Where
- Shanghai, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men and women aged 60 years or older who can take part in atrial fibrillation screening. It compares a blood pressure monitor with a single-lead ECG.
- Age
- 60 years or older
- Sex
- Men and women
Main reasons for not taking part
- Severe communication problems
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 125 years old?
Source: NCT06931288, who can take part
Where in China
- Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai 200025Shanghai, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shanghai Jiao Tong University School of Medicine
- Trial code
- NCT06931288
- Record updated
- 17 April 2025
- Original description
Study name: Study on the Effectiveness of Atrial Fibrillation Screening Using Electronic Blood Pressure Monitor with Atrial Fibrillation Detection FunctionRead full original descriptionShow less
Study on the Effectiveness of Atrial Fibrillation Screening Using Electronic Blood Pressure Monitor With Atrial Fibrillation Detection Function
Study name: Study on the Effectiveness of Atrial Fibrillation Screening Using Electronic Blood Pressure Monitor with Atrial Fibrillation Detection Function
Objective: This study compares an electronic blood pressure monitor (BP77A1T, Omron Healthcare, Kyoto, Japan) with single-lead electrocardiography for atrial fibrillation detection in an elderly Chinese population.
Study design: This study is a cluster-randomized and controlled trial.
Study population: Men and women aged over 60 years meeting the inclusion/exclusion criteria.
Randomization and treatment: Eligible centers as clusters will be randomly assigned to either the single-lead electrocardiography group or the electronic blood pressure monitor group for atrial fibrillation detection.
Sample size: About 50 centers, at least 20,000 participants.
Timeline: Participants enrollment are expected to be performed from May 2025 to July 2026.
Organization: The Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai, China.
Inclusion: Signed and dated informed consent form; Age ≥ 60 years; Able to cooperate with atrial fibrillation screening, complete questionnaires, and communicate normally.
Exclusion: Participants with severe communication problems.